Our greatest asset at ArsenalBio is our people. We’re thrilled to recognize our 2024 Mission Award recipients, Randy Reyes, JD, Corporate Counsel II, and Michelle Tan, Senior Scientist I. More on our team & open positions: bit.ly/3EgTl12 #CancerResearch

We're heading to the 9th Annual Tumor Models SF Summit this week. Thanks to ArsenalBio scientist Suchismita Mohanty, PhD, for presenting and serving as chair of the Drug Discovery & Screening track. Also, don't miss Alma Gomez's poster on preclinical research on AB-2100, our CAR

On World Cancer Day and EVERY day, we're committed to defeating solid tumor cancers. Solid tumors account for 90% of all cancers. At Arsenal, we're developing cell therapies to address the large unmet need that remains in multiple types of solid tumors. Our programmable

We are proud to celebrate International Day of Women and Girls in Science and the dedicated and talented women professionals at ArsenalBio. #WomeninScience #WomeninSTEM

Proud moment: ArsenalBio is officially Great Place To Work Certified. This recognition highlights our inclusive, innovative culture where people thrive and make an impact. More here: bit.ly/41mjLaP #GreatPlaceToWork #GPTWCertified

In a Q&A on Sōzō, the SoftBank Investment Advisors blog, CEO ken drazan describes how ArsenalBio's large language model (LLM) of the T cell works, the data that fuels the platform, and its powerful potential to accelerate drug development. Check it out: bit.ly/43dTfSq #AI

This Kidney Cancer Awareness Month, we reaffirm our commitment to developing cell therapies to defeat solid tumors such as kidney cancer. We are currently in a Phase 1/2 clinical study of AB-2100, our CAR T cell therapy for the potential treatment of clear-cell renal cell

Happy #EmployeeAppreciationDay to our 270 employees! We're so grateful for you and your many contributions toward our collective mission of defeating cancer. #CancerResearch #Biotech

It’s a busy week for ArsenalBio as we present at three scientific conferences: Supply Chain & Logistics for Cell & Gene Therapies Summit, Cell Therapy Potency Assay Summit, and SITC Spring Scientific Cellular Therapy for Solid Tumors. Details on the image.

ArsenalBio CSO Nick Haining recently spoke with Drug Discovery News about our multi-pronged approach of equipping T cells to defeat solid tumors. Check out the article, "Armoring up CAR T cells to fight solid tumors" at bit.ly/4i0LRO5 #CancerResearch #CellTherapy

Next week at the AACR Annual Meeting, we’ll share research on how our synthetic pathway activator (SPA) modules enhance the functional persistence of our CAR T cell therapies and prevent T cell exhaustion. bit.ly/4jbt8kj #AACR25 #CancerResearch

Our One Team value extends to our local community by helping our neighbors with a cleanup day. Happy Earth Day.

Future scientists at work! Each year at ArsenalBio, we hold a Bring a Kid to Work Day, where young minds explore our labs and experience the wonders of #STEM. #BringYourKidToWorkDay #TakeYourChildToWorkDay

We’re proud to share that ken drazan, MD, ArsenalBio’s Co-founder, CEO, and Chairman, has been recognized along with other inspiring business leaders as a finalist in the EY Entrepreneur Of The Year® 2025 Bay Area program. Learn more: go.ey.com/4jIJ7Xu #EOYUS #EOYBAYAREA

Heading to Fully Connected 2025? Hear from ArsenalBio’s Sofia Panagiotopoulou as she presents “A T-cell foundation model for AI-powered target discovery and precision medicine” on June 18. Learn more and view the full agenda: bit.ly/3FINBhW

We’re honored to have ken drazan, MD, Co-founder, CEO, and Chairman of the Board, recognized as a winner in the EY Entrepreneur Of The Year® 2025 Bay Area program. go.ey.com/4kI4eJI #EOYUS #EOYBAYAREA

CEO ken drazan, MD, will join a distinguished panel at Social in the City’s Biotech Strategic Meeting at the #NYSE on Friday. The panel will cover cell therapy inflection points and strategies for reaching capital efficiency and scientific value. bit.ly/4nqwXVm #SITC #cancer

Thanks to BiotechTV and Brad Loncar for sitting down with our CEO, ken drazan , M.D., to hear about the latest on our CAR T cell therapies specifically designed to overcome the challenges presented by solid tumors. Full video available here: bit.ly/46iJPqf #CancerResearch

On July 15 at the Process Development for Cell Therapies Summit, ArsenalBio scientist Max Lee will present during a workshop focused on implementing cutting-edge technology with phase-appropriate strategies. bit.ly/40agF90 #CellTherapy #Drug Development

Join ArsenalBio scientist Sophia Phillips on July 17 at the Process Development for Cell Therapies Summit for a case study on overcoming process development challenges in solid tumor-targeting cell therapies. bit.ly/40hBPCm #CellTherapy #DrugDevelopment